As of 2024-12-12, the Fair Value of Iovance Biotherapeutics Inc (IOVA) is -6.73 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.58 USD, the upside of Iovance Biotherapeutics Inc is -178.39%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -197.56 | -259.58 | -342.25 | -395.89 | -444.04 | -327.86 |
| YoY growth | -59.86% | -31.39% | -31.85% | -15.67% | -12.16% | -30.19% |
| Market Cap (mil) | 2,615.01 |
| P/E | |
| Forward P/E |
| EPS | -1.35 |
| Avg earnings growth rate | -30.19% |
| TTM earnings | -410.00 |